Schuler-Faccini L - Search Results

1

The impact of thalidomide use in birth defects in Brazil.

Sales Luiz Vianna F, Kowalski TW, Fraga LR, Sanseverino MT, Schuler-Faccini L. Sales Luiz Vianna F, et al. Eur J Med Genet. 2017 Jan;60(1):12-15. doi: 10.1016/j.ejmg.2016.09.015. Epub 2016 Sep 13. Eur J Med Genet. 2017. PMID: 27638330

2

Prenatal exposure to misoprostol and vascular disruption defects: a case-control study.

Vargas FR, Schuler-Faccini L, Brunoni D, Kim C, Meloni VF, Sugayama SM, Albano L, Llerena JC Jr, Almeida JC, Duarte A, Cavalcanti DP, Goloni-Bertollo E, Conte A, Koren G, Addis A. Vargas FR, et al. Am J Med Genet. 2000 Dec 11;95(4):302-6. doi: 10.1002/1096-8628(20001211)95:4<302::aid-ajmg2>3.0.co;2-b. Am J Med Genet. 2000. PMID: 11186881

3

Assessment of fetal risk associated with exposure to cancer chemotherapy during pregnancy: a multicenter study.

Peres RM, Sanseverino MT, Guimarães JL, Coser V, Giuliani L, Moreira RK, Ornsten T, Schüler-Faccini L. Peres RM, et al. Braz J Med Biol Res. 2001 Dec;34(12):1551-9. doi: 10.1590/s0100-879x2001001200007. Braz J Med Biol Res. 2001. PMID: 11717708 Free article.

4

New cases of thalidomide embryopathy in Brazil.

Schuler-Faccini L, Soares RC, de Sousa AC, Maximino C, Luna E, Schwartz IV, Waldman C, Castilla EE. Schuler-Faccini L, et al. Birth Defects Res A Clin Mol Teratol. 2007 Sep;79(9):671-2. doi: 10.1002/bdra.20384. Birth Defects Res A Clin Mol Teratol. 2007. PMID: 17676592

5

Prospective evaluation of pregnant women vaccinated against rubella in southern Brazil.

Minussi L, Mohrdieck R, Bercini M, Ranieri T, Sanseverino MT, Momino W, Callegari-Jacques SM, Schuler-Faccini L. Minussi L, et al. Reprod Toxicol. 2008 Jan;25(1):120-3. doi: 10.1016/j.reprotox.2007.09.002. Epub 2007 Sep 16. Reprod Toxicol. 2008. PMID: 17977696

6

Epidemiological surveillance of birth defects compatible with thalidomide embryopathy in Brazil.

Vianna FS, Lopez-Camelo JS, Leite JC, Sanseverino MT, Dutra Mda G, Castilla EE, Schüler-Faccini L. Vianna FS, et al. PLoS One. 2011;6(7):e21735. doi: 10.1371/journal.pone.0021735. Epub 2011 Jul 6. PLoS One. 2011. PMID: 21754997 Free PMC article.

7

Maternal SNPs in the p53 pathway: risk factors for trisomy 21?

Boquett JA, Brandalize AP, Fraga LR, Schuler-Faccini L. Boquett JA, et al. Dis Markers. 2013;34(1):41-9. doi: 10.3233/DMA-2012-00937. Dis Markers. 2013. PMID: 23089923 Free PMC article.

8

Recognition of the phenotype of thalidomide embryopathy in countries endemic for leprosy: new cases and review of the main dysmorphological findings.

Vianna FSL, Schüler-Faccini L, Leite JCL, de Sousa SHC, da Costa LMM, Dias MF, Morelo EF, Doriqui MJR, Maximino CM, Sanseverino MTV. Vianna FSL, et al. Clin Dysmorphol. 2013 Apr;22(2):59-63. doi: 10.1097/MCD.0b013e32835ffc58. Clin Dysmorphol. 2013. PMID: 23448904 Review.

9

Polymorphisms in the endothelial nitric oxide synthase gene in thalidomide embryopathy.

Vianna FS, Fraga LR, Tovo-Rodrigues L, Tagliani-Ribeiro A, Biondi F, Maximino CM, Sanseverino MT, Hutz MH, Schuler-Faccini L. Vianna FS, et al. Nitric Oxide. 2013 Nov 30;35:89-92. doi: 10.1016/j.niox.2013.09.002. Epub 2013 Sep 17. Nitric Oxide. 2013. PMID: 24055736

10

p53 signaling pathway polymorphisms associated to recurrent pregnancy loss.

Fraga LR, Dutra CG, Boquett JA, Vianna FS, Gonçalves RO, Paskulin DD, Costa OL, Ashton-Prolla P, Sanseverino MT, Schuler-Faccini L. Fraga LR, et al. Mol Biol Rep. 2014 Mar;41(3):1871-7. doi: 10.1007/s11033-014-3036-6. Epub 2014 Jan 17. Mol Biol Rep. 2014. PMID: 24435975

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

199 results

Search Page